Alerts will be sent to your verified email
Verify EmailSYNGENE
|
Syngene Internatl.
|
Piramal Pharma
|
Laurus Labs
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Pharmaceuticals
|
|||
|
Fermentation Capacity
|
n/a | n/a | 240.0 KL |
|
Financials
|
|||
|
5 yr Average ROE
|
10.77 % | 1.39 % | 14.55 % |
|
5yr average Equity Multiplier
|
1.51 | 1.99 | 2.02 |
|
5yr Average Asset Turnover Ratio
|
0.53 | 0.53 | 0.67 |
|
5yr Avg Net Profit Margin
|
13.29 % | 0.13 % | 10.48 % |
|
Price to Book
|
3.5 | 2.85 | 15.88 |
|
P/E
|
53.45 | 0.0 | 94.68 |
|
5yr Avg Cash Conversion Cycle
|
-17422.74 Days | -54.64 Days | 70.98 Days |
|
Inventory Days
|
21.99 Days | 75.95 Days | 118.83 Days |
|
Days Receivable
|
50.33 Days | 78.2 Days | 111.49 Days |
|
Days Payable
|
3896.59 Days | 172.59 Days | 145.11 Days |
|
5yr Average Interest Coverage Ratio
|
14.45 | 1.59 | 6.55 |
|
5yr Avg ROCE
|
12.58 % | 4.67 % | 18.35 % |
|
5yr Avg Operating Profit Margin
|
27.94 % | 12.64 % | 23.14 % |
|
5 yr average Debt to Equity
|
0.09 | 0.65 | 0.53 |
|
5yr CAGR Net Profit
|
-4.36 % | n/a | 1.44 % |
|
5yr Average Return on Assets
|
7.1 % | 0.1 % | 7.26 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
52.68 % | 34.86 % | 27.49 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 2.69 % |
|
Change in Promoter Holding (3 Yrs)
|
-2.2 % | 0.07 % | 0.29 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
15.83 % | 13.59 % | 5.82 % |
|
Syngene Internatl.
|
Piramal Pharma
|
Laurus Labs
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|